-transparent.png){kind=logo}
Worsening of glycemic control in type 2 Diabetes mellitus occur on account of declining beta cell function. This calls for up titration of the chosen drug, addition of another agent with complementary action and eventually insulin usually after 2 or three OADs. Introduction of insulin has many issues which include parenteral route of administration, cost and enhancement of hypoglycemic tendency. We propose the addition of another OAD in lieu of insulin in whom glycemic control can be achieved equally well without insulin.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Jayant Kelwade, and
Harsh Parekh, and
Vaibhav Dukle, and
Bipin Kumar Sethi
January 1975,
International anesthesiology clinics,
Jayant Kelwade, and
Harsh Parekh, and
Vaibhav Dukle, and
Bipin Kumar Sethi
December 1999,
European journal of endocrinology,
Jayant Kelwade, and
Harsh Parekh, and
Vaibhav Dukle, and
Bipin Kumar Sethi
January 1999,
Duodecim; laaketieteellinen aikakauskirja,
Jayant Kelwade, and
Harsh Parekh, and
Vaibhav Dukle, and
Bipin Kumar Sethi
May 1976,
Australian family physician,
Jayant Kelwade, and
Harsh Parekh, and
Vaibhav Dukle, and
Bipin Kumar Sethi
May 2000,
MMW Fortschritte der Medizin,
Jayant Kelwade, and
Harsh Parekh, and
Vaibhav Dukle, and
Bipin Kumar Sethi
March 1993,
Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
Jayant Kelwade, and
Harsh Parekh, and
Vaibhav Dukle, and
Bipin Kumar Sethi
February 1975,
Zeitschrift fur Allgemeinmedizin,
Jayant Kelwade, and
Harsh Parekh, and
Vaibhav Dukle, and
Bipin Kumar Sethi
January 1999,
La Revue du praticien,
Jayant Kelwade, and
Harsh Parekh, and
Vaibhav Dukle, and
Bipin Kumar Sethi
December 1958,
Folia medica Neerlandica,
Jayant Kelwade, and
Harsh Parekh, and
Vaibhav Dukle, and
Bipin Kumar Sethi
November 1971,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
